Patients with definite APS (+/− SLE) and first venous event
|
aVK, INR range of 2.0-3.0
|
Patients with definite APS (+/− SLE) and venous recurrent thromboembolism during aVK or arterial thrombosis*
|
aVK, target INR > 3.0a
|
or
|
combination of aspirin (100 mg daily) and aVK, INR range 2.0-3.0a
|
APS patients (without SLE) with a first non cardioembolic cerebral arterial event, low-risk aPL profile, and reversible predisposing factors
|
Antiplatelet agents
|
SLE patients with venous or arterial thrombosis who do not fulfil APS laboratory classification criteria
|
Same as patients from the general population who develop venous or arterial thrombosis
|